The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Therapeutic Angiogenesis

Toshio Matsuhashi, MD; Dara L. Kraitchman, VMD, PhD; and Lawrence V. Hofmann, MD

July 2005—Is peripheral arterial disease treatment evolving from stents to stem cells?

A Safe and Effective Primary Treatment Option

Lawrence A. Garcia, MD, and James F. McKinsey, MD

August 2005—Peripheral arterial disease (PAD) remains a major cause of disability, loss of work, and lifestyle changes in the US.1-6 Symptoms of PAD can vary from disabling pain with ambu…

Stenting in Long, Complex Lesions Is Superior to the “Old Standard”

Mark W. Mewissen, MD

August 2005—Endovascular treatment strategies for the relief of symptomatic lower-extremity peripheral vascular disease, secondary to femoropopliteal (FP) artery disease are changing at a…

Comparative Data Are Still Necessary

Barry T. Katzen, MD

August 2005—Endovascular therapy has clearly come a long way in recent years. Our techniques and technology have improved, and we continue to see new therapeutic options enter the arena, …

Regulation of Peripheral Vascular Devices

David S. Buckles; Jennifer L. Goode; and Dorothy B. Abel

August 2005—Current issues in the regulation of SFA stents.

Plaque Excision in 2005 and Beyond: Rebuttal

Lawrence A. Garcia, MD, and James F. McKinsey, MD

September 2005—Rebuttal of “Issues of the Past Have Yet to Be Resolved”

An Interview With Gary Ansel, MD

Gary Ansel, MD

September 2005—A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.

The RESILIENT Trial Update: 6-Month Phase 1 Results

John R. Laird, Jr, MD

October 2005—Encouraging data include no reinterventions, 100% clinical success, and no stent fractures.

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.